search
Back to results

BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears

Primary Purpose

Rotator Cuff Tears

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Arthroscopic rotator cuff repair with BioBrace® Implant augmentation.
Arthroscopic rotator cuff repair
Sponsored by
CONMED Corporation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Rotator Cuff Tears focused on measuring Rotator cuff tear, Full thickness tear, BioBrace

Eligibility Criteria

40 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Male or female 40 to 70 years old Positive diagnostic imaging by MRI within 6 months of enrollment of the index shoulder indicating a full thickness rotator cuff tear (RCT): Tear of the supraspinatus and/or infraspinatus tendons Tear size ≥ 2 cm and < 5 cm Chronic shoulder pain ≥ 3 months Failed non-operative treatment of the index shoulder to include one or all of the following: Oral analgesics Nonsteroidal anti-inflammatory medications (NSAIDs) Corticosteroid injections Activity modifications Physical therapy or home-guided exercises Able to read and understand the study REB/IRB approved Informed Consent Form (ICF) Willing to be available to attend each protocol-required follow-up examination Able to speak, read and understand English Intraoperative Inclusion Criteria: Full thickness tear of the supraspinatus and/or infraspinatus tendons Tear size ≥ 2 cm and < 5 cm Able to reapproximate the tendons to cover > 50% of the footprint on the greater tuberosity Exclusion Criteria: Previous surgery of the index shoulder one year prior to the study surgery excluding diagnostic arthroscopy Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3 (Goutallier Score) Major medical condition that could affect quality of life and influence the results of the study (e.g., HIV or other immunosuppressive conditions, active malignancy in the past 5 years, acute MI, CVA, etc.) Oral steroid use or steroid injection within 6 weeks prior to surgery Active smoker History of insulin-dependent diabetes Documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment Hypersensitivity to any investigational device materials including collagen of animal origin (bovine type-I), poly-L-lactic acid (PLLA) or polyethylene glycol (PEG) Presence of an implanted metallic device or other implants that would contraindicate acquisition or inhibit radiologist review of an MRI of the index shoulder History of claustrophobia that would prevent an MRI of the index shoulder Females of child-bearing potential who are either pregnant or breastfeeding or plan to become pregnant during the course of the study Currently participating, or plans to enroll in another clinical trial during this study that would affect the outcomes of this study as determined by the Investigator History of non-compliance with medical treatment or clinical trial participation The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant with protocol required follow-up Any comorbidity or condition that renders the patient a poor surgical candidate as determined by the Investigator The subject is receiving prescription narcotic pain medication The subject currently has an acute infection in the area surrounding the surgical site Contralateral shoulder condition where rotator cuff repair is scheduled or to be scheduled over the course of this study The subject's condition represents a worker's compensation case COVID-19 positive at hospital admission Intraoperative Exclusion Criteria: 1. Subject requires subscapularis repair other than a repair with a single anchor

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    BioBrace Augment Group

    Repair Only Group

    Arm Description

    An arthroscopic rotator cuff repair is performed with the BioBrace Implant fixed on top of the repaired tendon using anchors.

    An arthroscopic rotator cuff repair is performed using standard surgical procedure.

    Outcomes

    Primary Outcome Measures

    6 Month Retear Rate
    The between-group difference in radiological incidence (MRI) of a Sugaya Type IV or V full-thickness discontinuity at postoperative Month 6.

    Secondary Outcome Measures

    12 Month Retear Rate
    The between-group difference in radiological incidence (MRI) of Sugaya Type IV or V full-thickness discontinuity at postoperative Month 12.
    Single Assessment Numeric Evaluation (SANE)
    Adjusted mean between-group difference in SANE score from baseline to 6 weeks, 3-, 6-, and 12-months post-op
    Western Ontario Rotator Cuff Index (WORC)
    Adjusted mean between-group difference in WORC score from baseline to 6 weeks, 3-, 6-, and 12-months post-op
    EuroQOL Five Dimensions Questionnaire (EQ-5D-5L)
    Adjusted mean between-group difference in health-related, quality of life from baseline to 6 weeks, 3-, 6-, and 12-months post-op

    Full Information

    First Posted
    August 10, 2023
    Last Updated
    August 10, 2023
    Sponsor
    CONMED Corporation
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05997381
    Brief Title
    BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
    Official Title
    A Prospective, Single Blind, Multi-Center, Randomized, Controlled, Pivotal Study to Evaluate the Safety and Effectiveness of the BioBrace® Implant During Arthroscopic Repair of Full Thickness Rotator Cuff Tears
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 2023 (Anticipated)
    Primary Completion Date
    June 2025 (Anticipated)
    Study Completion Date
    December 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    CONMED Corporation

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Product Manufactured in and Exported from the U.S.
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    This study aims to evaluate the safety and effectiveness of arthroscopic rotator cuff repair augmented with the BioBrace® Implant vs. arthroscopic rotator cuff repair alone in subjects requiring surgical intervention for a full-thickness rotator cuff tear.
    Detailed Description
    This is a prospective, single blind, multi-center, randomized, controlled, pivotal clinical study investigating the treatment of full thickness tears of the rotator cuff. Tears must involve the supraspinatus and/or infraspinatus tendons and measure ≥ 2 cm and < 5 cm. Subjects meeting the inclusion/exclusion criteria will be enrolled and will undergo either arthroscopic rotator cuff repair augmented with the BioBrace® Implant or arthroscopic rotator cuff repair alone. Clinical evaluations will be conducted at baseline (pre-operatively) and at 6 weeks, 3-, 6-, and 12-months post-operatively using various patient-reported outcome measures and MRI to assess repair integrity and re-tear rate.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Rotator Cuff Tears
    Keywords
    Rotator cuff tear, Full thickness tear, BioBrace

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    268 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    BioBrace Augment Group
    Arm Type
    Experimental
    Arm Description
    An arthroscopic rotator cuff repair is performed with the BioBrace Implant fixed on top of the repaired tendon using anchors.
    Arm Title
    Repair Only Group
    Arm Type
    Sham Comparator
    Arm Description
    An arthroscopic rotator cuff repair is performed using standard surgical procedure.
    Intervention Type
    Device
    Intervention Name(s)
    Arthroscopic rotator cuff repair with BioBrace® Implant augmentation.
    Intervention Description
    An arthroscopic rotator cuff repair will be performed and augmented with the BioBrace® Implant. The BioBrace® Implant is intended for use in surgical procedures for reinforcement of soft tissue where weakness exists. It is a bioresorbable, biocomposite scaffold composed of a highly porous collagen sponge and reinforced with poly-L-lactic-acid (PLLA). When used in rotator cuff repairs, it is placed on top of the tendons to augment and reinforce the underlying repair. The BioBrace® is designed to mechanically and biologically augment weakened or torn soft tissue and can be integrated into surgeons' standard of care rotator cuff repair techniques.
    Intervention Type
    Procedure
    Intervention Name(s)
    Arthroscopic rotator cuff repair
    Intervention Description
    An arthroscopic rotator cuff repair is performed using standard surgical procedure.
    Primary Outcome Measure Information:
    Title
    6 Month Retear Rate
    Description
    The between-group difference in radiological incidence (MRI) of a Sugaya Type IV or V full-thickness discontinuity at postoperative Month 6.
    Time Frame
    6 months post-op
    Secondary Outcome Measure Information:
    Title
    12 Month Retear Rate
    Description
    The between-group difference in radiological incidence (MRI) of Sugaya Type IV or V full-thickness discontinuity at postoperative Month 12.
    Time Frame
    12 months post-op
    Title
    Single Assessment Numeric Evaluation (SANE)
    Description
    Adjusted mean between-group difference in SANE score from baseline to 6 weeks, 3-, 6-, and 12-months post-op
    Time Frame
    Baseline, 6 weeks, 3-, 6-, and 12-months post-op
    Title
    Western Ontario Rotator Cuff Index (WORC)
    Description
    Adjusted mean between-group difference in WORC score from baseline to 6 weeks, 3-, 6-, and 12-months post-op
    Time Frame
    Baseline, 6 weeks, 3-, 6-, and 12-months post-op
    Title
    EuroQOL Five Dimensions Questionnaire (EQ-5D-5L)
    Description
    Adjusted mean between-group difference in health-related, quality of life from baseline to 6 weeks, 3-, 6-, and 12-months post-op
    Time Frame
    Baseline, 6 weeks, 3-, 6-, and 12-months post-op

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    40 Years
    Maximum Age & Unit of Time
    70 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Male or female 40 to 70 years old Positive diagnostic imaging by MRI within 6 months of enrollment of the index shoulder indicating a full thickness rotator cuff tear (RCT): Tear of the supraspinatus and/or infraspinatus tendons Tear size ≥ 2 cm and < 5 cm Chronic shoulder pain ≥ 3 months Failed non-operative treatment of the index shoulder to include one or all of the following: Oral analgesics Nonsteroidal anti-inflammatory medications (NSAIDs) Corticosteroid injections Activity modifications Physical therapy or home-guided exercises Able to read and understand the study REB/IRB approved Informed Consent Form (ICF) Willing to be available to attend each protocol-required follow-up examination Able to speak, read and understand English Intraoperative Inclusion Criteria: Full thickness tear of the supraspinatus and/or infraspinatus tendons Tear size ≥ 2 cm and < 5 cm Able to reapproximate the tendons to cover > 50% of the footprint on the greater tuberosity Exclusion Criteria: Previous surgery of the index shoulder one year prior to the study surgery excluding diagnostic arthroscopy Fatty infiltration of the index shoulder rotator cuff muscle ≥ Grade 3 (Goutallier Score) Major medical condition that could affect quality of life and influence the results of the study (e.g., HIV or other immunosuppressive conditions, active malignancy in the past 5 years, acute MI, CVA, etc.) Oral steroid use or steroid injection within 6 weeks prior to surgery Active smoker History of insulin-dependent diabetes Documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment Hypersensitivity to any investigational device materials including collagen of animal origin (bovine type-I), poly-L-lactic acid (PLLA) or polyethylene glycol (PEG) Presence of an implanted metallic device or other implants that would contraindicate acquisition or inhibit radiologist review of an MRI of the index shoulder History of claustrophobia that would prevent an MRI of the index shoulder Females of child-bearing potential who are either pregnant or breastfeeding or plan to become pregnant during the course of the study Currently participating, or plans to enroll in another clinical trial during this study that would affect the outcomes of this study as determined by the Investigator History of non-compliance with medical treatment or clinical trial participation The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant with protocol required follow-up Any comorbidity or condition that renders the patient a poor surgical candidate as determined by the Investigator The subject is receiving prescription narcotic pain medication The subject currently has an acute infection in the area surrounding the surgical site Contralateral shoulder condition where rotator cuff repair is scheduled or to be scheduled over the course of this study The subject's condition represents a worker's compensation case COVID-19 positive at hospital admission Intraoperative Exclusion Criteria: 1. Subject requires subscapularis repair other than a repair with a single anchor
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Gowri Viswanathan, MS
    Phone
    914-334-2498
    Email
    GowriViswanathan@conmed.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jeffery Grebner, MS
    Phone
    651-367-4956
    Email
    JefferyGrebner@conmed.com

    12. IPD Sharing Statement

    Learn more about this trial

    BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears

    We'll reach out to this number within 24 hrs